David Hollander
Chief R&D Officer · Veradermics, Inc
IndividualSelling only
- 2024
- Sep 3, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Hollander files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- John W. Childs - $20.71M in MANE purchases and sales in the last 12 months
- Patrick G. Enright - $18.27M in MANE purchases and sales in the last 12 months
- Longitude Capital Partners V, LLC - $18.27M in MANE purchases and sales in the last 12 months
- Reid Alexander Waldman - $7.28M in MANE purchases and sales in the last 12 months
- Timothy August Durso - $4.69M in MANE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Hollander?
David Hollander is a corporate insider, tracked as Chief R&D Officer of Veradermics, Inc (MANE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Hollander submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David Hollander been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($16K) across all tracked filings.
